Table 2.
Number of gameplays, demographics, and baseline scores of participants receiving high and low doses of Lumosity
| Low-Dose | High-Dose | 1p-value | |
|---|---|---|---|
| NCPT | |||
| Mean (range) Gameplays | 11.8 (0–25) | 757.5 (400–1994) | NA |
| N Participants | 616 | 1330 | NA |
| Mean (sd) Age | 45.5 (15.9) | 45.5 (15.1) | 0.981 |
| Gender (% M/F/Unknown) | 43.8/48.5/7.6 | 38.7/54.6/6.7 | 0.046* |
| Baseline – GI (points) | |||
| Mean (sd) Raw | 100.3 (13.3) | 102.0 (14.0) | 0.012* |
| 2Mean (sd) Adjusted | 95.4 (11.4) | 97.0 (11.9) | 0.005** |
| BAMS-7 | |||
| Mean (range) Gameplays | 8.9 (0–25) | 816 (400–1989) | NA |
| N Participants | 79 | 191 | NA |
| Mean (sd) Age | 43.8 (15.4) | 44.3 (15.2) | 0.795 |
| Gender (% M/F/Unknown) | 41.8/54.4/3.8 | 36.7/60.2/3.1 | 0.679 |
| Baseline – Attention (points) | |||
| Mean (sd) Raw | 2.60 (0.94) | 2.57 (0.84) | 0.814 |
| 2Mean (sd) Adjusted | 2.69 (0.91) | 2.65 (0.83) | 0.798 |
| Baseline – Mood (points) | |||
| Mean (sd) Raw | 2.63 (1.03) | 2.77 (0.91) | 0.320 |
| 2Mean (sd) Adjusted | 2.76 (1.03) | 2.89 (0.89) | 0.314 |
1 Based on Welch’s t tests for Age and Baseline and Chi-sq tests for Gender.
2Adjusted for differences in age and gender between participants receiving high and low doses of CT.
**p < 0.01, *p < 0.05.